DNCA Finance’s DexCom DXCM Stock Holding History

DNCA Finance’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.71M	Buy	75,000 +28,000	+60%	+$1.95M	0.27%	56
2025 Q4	$3.12M	Buy	+47,000	New	+$3.04M	0.18%	63

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DNCA Finance's DXCM Position: Q1 2026 in Review

DNCA Finance increased its DexCom (DXCM) stake by 60% in Q1 2026, buying an estimated $1.95M and bringing the position to 75,000 shares worth $4.71M. The position accounts for 0.27% of the portfolio, ranked #56.

DNCA Finance first reported a position in DXCM in Q4 2025 and has held it in 2 quarters since. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

DNCA Finance held 75,000 shares of DexCom worth $4.71M as of Q1 2026.
DNCA Finance bought 28,000 DexCom shares in Q1 2026, an estimated $1.95M.
DexCom made up 0.27% of DNCA Finance's portfolio in Q1 2026, its #56 holding.
DNCA Finance first reported a position in DexCom in Q4 2025 and has held it in 2 quarters since.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on DNCA Finance's 13F filing for Q1 2026, filed 14 May 2026.